AKT1 and myeloid leukemia: On myeloid leukemia cell lines, blueberry extracts (25 mg/week) show anti-AML actions, which are mediated via the regulation of protein kinase B (Akt) and extracellular signal regulated kinase (Erk) within the leukemic stem cell fraction [87].